Company intelligence / Profile preview

Azidus Brasil

Valinhos, São Paulo, Brazil

Ownership: Private
Employees: ~46
Development stage: Other

Overview

Has conducted 3 clinical trials including completed Phase 1 studies and ongoing Phase 3 trials for testosterone replacement therapy and Huntington's disease treatment

Therapeutic areas: NeurologyEndocrinology
Modalities: BiologicsSmall moleculeStem cell therapy
Industry: Contract Research Organization

Partnerships

Biozeus Biopharmaceutical SAFBM Industria Brasileira Ltda

Beyond the preview

Go deeper on Azidus Brasil.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Azidus Brasil.

Explore the full profile